SK Plasma has grown steadily on the foundation of PDMP (plasma-derived medicinal products) business starting from 1970. In 2015, SK Plasma resolved to build a state-of-the-art plasma fractionation plant and has spun off from SK Chemicals Life Science biz., aiming to improve competitiveness in the global PDMP market. SK Plasma is planning to build a plasma fractionation plant in order to improve the self-sufficiency of PDMP in Indonesia through a joint venture with capable business partners under the support of the Indonesian government.
Role Description :
A. Qualification :
B. Validation :
Qualifications :
Required :
Preferably :